L11.8 – Acantholytic Disorder ICD-10 Code
L11.8 is an ICD-10 code for other specified acantholytic disorders – rare skin conditions characterised by a loss of cell-to-cell cohesion in the epidermis.
Things worth knowing about "L11.8"
L11.8 is an ICD-10 code for other specified acantholytic disorders – rare skin conditions characterised by a loss of cell-to-cell cohesion in the epidermis.
What Does the ICD-10 Code L11.8 Mean?
The code L11.8 comes from the International Classification of Diseases (ICD-10) and stands for other specified acantholytic disorders. It is used when a skin disease belonging to the group of acantholytic conditions is present but does not fall under a more specific code within this category. Acantholytic disorders are skin diseases in which the cohesion between keratinocytes – the primary cells of the outer skin layer (epidermis) – is disrupted. This leads to the formation of blisters, erosions, or scaling skin changes.
What Is Acantholysis?
Acantholysis refers to the loss of cell-to-cell contact between keratinocytes in the epidermis. Under normal conditions, specialised junctional structures called desmosomes hold skin cells firmly together. In acantholytic diseases, these structures are damaged by autoantibodies, genetic defects, or other mechanisms. The affected cells separate from one another, creating spaces within the epidermis that manifest as blisters or erosions.
Which Conditions Are Coded Under L11.8?
The code L11.8 groups together various rare dermatoses that show acantholytic features but cannot be assigned to the more specific codes L10 (Pemphigus), L11.0 (acquired keratosis follicularis), or L11.1 (transient acantholytic dermatosis). Examples include:
- Acantholytic dyskeratosis: Characterised by acantholysis combined with dyskeratosis (abnormal cornification of individual cells).
- Focal acantholytic dyskeratosis: A localised variant, often found incidentally in skin biopsies.
- Rare variants of acantholytic diseases that do not correspond to any other specific entity.
Causes
The causes of acantholytic dermatoses under L11.8 are diverse and depend on the underlying condition:
- Genetic mutations: Defects in genes encoding desmosomal proteins or keratins can weaken cell cohesion.
- Autoimmune processes: Autoantibodies against desmogleins or other adhesion proteins lead to disruption of the cell layer.
- Medications: Certain drugs (e.g., penicillamine, ACE inhibitors) can trigger acantholytic reactions.
- UV radiation: Can trigger acantholytic processes in predisposed individuals.
- Idiopathic causes: In some cases, the cause remains unclear.
Symptoms
The clinical presentation can vary depending on the underlying disease. Common symptoms include:
- Flaccid or tense blisters on the skin or mucous membranes
- Erosions and crusts following rupture of blisters
- Itching or burning in the affected area
- Scaling and hyperkeratosis (thickening of the outer skin layer)
- Erythematous (reddened) patches
Diagnosis
The diagnosis of an acantholytic dermatosis typically requires several examination steps:
- Clinical examination: Assessment of the appearance of skin lesions.
- Skin biopsy with histology: Detection of acantholysis and possible dyskeratosis under the microscope – this is the most important diagnostic step.
- Direct immunofluorescence (DIF): To detect antibody deposits in the skin, relevant in autoimmune forms.
- Serology: Determination of autoantibodies (e.g., anti-desmoglein-1 and -3) in the blood.
- Genetic testing: If a hereditary form is suspected.
Treatment
Treatment is guided by the specific diagnosis and severity of the condition. General therapeutic approaches include:
- Topical corticosteroids: To reduce local inflammatory responses.
- Systemic corticosteroids: For extensive or severe forms.
- Immunosuppressants (e.g., azathioprine, mycophenolate mofetil): For autoimmune-related diseases.
- Retinoids (e.g., acitretin): Especially for dyskeratotic variants.
- Wound care and skin care: Supportive measures to prevent infections.
- Discontinuation of triggering medications: In drug-induced acantholysis.
Note on ICD Coding
The code L11.8 is a so-called residual code used in clinical documentation when the exact diagnosis within the group of acantholytic dermatoses cannot be assigned to a more precise ICD-10 code. The most accurate diagnosis possible and, if necessary, additional coding of accompanying findings is recommended.
References
- World Health Organization (WHO): ICD-10 International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Chapter XII – Diseases of the Skin and Subcutaneous Tissue (L00–L99).
- Braun-Falco's Dermatology, 3rd English Edition, Springer Medizin Verlag.
- Murrell DF et al.: Definitions and outcome measures for bullous diseases – a consensus statement. Journal of the American Academy of Dermatology, 2012.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: L11.8